Loyola Medicine Prepares for Possible Approval of the COVID-19 Vaccine for Children

The Food and Drug Administration (FDA) is set to meet on October 26 to discuss the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for children aged five to 11. Ahead of this meeting, Loyola Medicine is taking steps to ensure the health system is prepared to administer Pfizer vaccines to children if approval is granted.